JPMORGAN ASSET MANAGEMENT (CHINA) C SID MORGAN INNOVATIVE PHARMACEUTICAL INDJPMORGAN ASSET MANAGEMENT (CHINA) C SID MORGAN INNOVATIVE PHARMACEUTICAL INDJPMORGAN ASSET MANAGEMENT (CHINA) C SID MORGAN INNOVATIVE PHARMACEUTICAL IND

JPMORGAN ASSET MANAGEMENT (CHINA) C SID MORGAN INNOVATIVE PHARMACEUTICAL IND

Inga transaktioner
Se i superdiagram

Om JPMORGAN ASSET MANAGEMENT (CHINA) C SID MORGAN INNOVATIVE PHARMACEUTICAL IND

Issuer
JPMorgan Chase & Co.
Brand
CIFM
Expense ratio
0.40%
Home page
Inception date
9 maj 2022
Index tracked
CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross
Management style
Passive
ISIN
CNE100005B86

Classification

Asset Class
Equity
Kategori
Sektor
Focus
Sjukvård
Niche
Apotek
Weighting scheme
Börsvärde
Selection criteria
Börsvärde

Returns

1 månad3 månaderHittills i år1 år3 år5 år
Price performance
NAV total return

What's in the fund

As of 31 december 2023
Exposure type
AktierBonds, Cash & Other
Hälsoteknik
Aktier99.84%
Hälsoteknik90.66%
Kommersiella tjänster8.37%
Processindustrier0.50%
Hälsotjänster0.31%
Bonds, Cash & Other0.16%
Likvida medel0.16%
Stock breakdown by region
100%
Asien100.00%
Nordamerika0.00%
Latinamerika0.00%
Europa0.00%
Afrika0.00%
Mellanöstern0.00%
Oceanien0.00%
Top 10 holdings

Utdelningar

Utdelningshistorik

Assets under management (AUM)

Fund Flows